Anti-VEGF Treatment of Anterior Segment Disorders of the Eye

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|7|2|123-125

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.7, Iss.2, 2012-06, pp. : 123-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-VEGF Treatment of Glaucoma

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 126-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Treatment of Diabetic Retinopathy

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 96-100

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Non-Conventional Applications of Anti-VEGF Treatment in Selected Retinal Diseases

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 90-95

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 77-79

Bentham Science Publishers

Access to resources Recommend Favorite